Malignant gliomas and medulloblastomas — the most common brain tumours affecting adults and children, respectively — remain responsible for a disproportionate level of morbidity and mortality ...

NeOnc Technologies Holdings, Inc. (NASDAQ Global Market: NTHI) , a clinical-stage medical biotechnology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Rare ...

On March 21, in Shenyang, Liaoning, young top athlete Wu Zhonghua shared a heartfelt video revealing his ongoing health challenges. Despite facing a suspected tumor in his ear following a battle with ...

Pediatric high-grade gliomas, particularly H3K27M diffuse midline gliomas (DMG), are aggressive malignant brain tumors with a poor prognosis.

Glioblastoma multiforme (GBM), commonly referred to as glioblastoma, is a malignant intracranial tumor derived from glial ...

An international team of clinical collaborators, led by physician scientists from Dana-Farber Cancer Institute, performed a ...

Pediatric high-grade gliomas, particularly H3K27M diffuse midline gliomas (DMG), are aggressive malignant brain tumors with a poor prognosis. Previous research suggests that platelet-derived growth ...

A recent study published in MedComm – Future Medicine by a research team from Fudan University provides an in-depth ...

NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI) shares slid as the Westlake Village, Calif.-based company a clinical-stage medical biotechnology concerm, announced that the U.S. Food and Drug ...